Share Your Feedback
Shennon Biotechnologies
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Funding
Early Stage
Current Stage
$13M
Recent Funding
$13M
Total Funding
Leadership Team
Li Sun, PhD
Founder/CEO